Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer

NCT01196429 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

NIH

Sponsor class

Conditions

Ovarian Clear Cell Cystadenocarcinoma
Stage III Ovarian Cancer
Stage IV Ovarian Cancer

Interventions

DRUG: Carboplatin
DRUG: Docetaxel
OTHER: Laboratory Biomarker Analysis
DRUG: Paclitaxel
DRUG: Temsirolimus

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]